undamentalytics Newsletter
Sign in

Pyxis Oncology, Inc. balance sheet

At the end of fiscal 2025, Pyxis Oncology, Inc. had total assets of $91.5m, total liabilities of $38.1m and shareholders' equity of $53.4m. It held $15.4m in cash against $0 of debt: net cash of $15.4m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2024Dec 20242025Dec 2025
Cash and equivalents1915
Total current assets13272
Total assets15792
Accounts payable511
Total current liabilities1821
Total debt00
Total liabilities3638
Shareholders' equity12153
Net debt (negative = net cash)−19−15
Shares outstanding60m63m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: KROS vs PYXSPRQR vs PYXSCTMX vs PYXS

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Pyxis Oncology, Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Pyxis Oncology, Inc.